RecruitingNCT05227924

Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty

Sponsor

Dedienne Sante S.A.S.

Enrollment

747 participants

Start Date

Sep 21, 2021

Study Type

OBSERVATIONAL

Conditions

Avascular Necrosis of the Femoral Head Post-traumatic Osteoarthritis Hip Arthritis Femoral Neck Fractures Degenerative Hip Joint Disease Failure of Prosthetic Joint Implant

Summary

The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty using medical devices from SYMBOL range over a period of 10 years.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Patient age \> 18 years at implantation.
Patient who will undergo, during the study's period of inclusion, a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device (DEDIENNE Santé).
Patient informed of his/her participation and willing to participate in the study.
Patient able to read, write and understand French.

Exclusion Criteria3

Patient deprived of freedom, under guardianship/curatorship or placed under judicial protection
Patient unable to follow study procedures.
Patient who has already been included in the study for a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.